Hilary McElwaine-Johnn
Hilary McElwaine-Johnn publishes mostly in Oncology, Molecular Biology and Genetics, on topics such as Virus-based gene therapy research, Cancer Research and Treatments and CAR-T cell therapy research.
- World rank
- #2,392,996 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #170,376 of 367,258
- Works
- 27
- Citations
- 354
- Citations per work
- 13.1
What does Hilary McElwaine-Johnn research?
Hilary McElwaine-Johnn's work is mostly in Biochemistry, Genetics and Molecular Biology (47%), Medicine (28%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1347.3%
- Health Sciences828.1%
- Medicine828.1%
- Everything else724.6%
- 1Oncology21% of their works
- 2Molecular Biology18% of their works
- 3Genetics16% of their works
- 4Biotechnology14% of their works
- 5Epidemiology4% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
Which keywords describe Hilary McElwaine-Johnn's research?
The keywords of their largest research topics: Gene Therapy, Immunotherapy, Tumor Regression, AAV, Viral Vectors, Bacterial Therapy, Tumor Targeting and Cancer Therapy.
- PROTACs
- Histone Modification
- Benign Prostatic Hyperplasia
- Tumor Microenvironment
- Histone Deacetylases
- Chimeric Antigen Receptor
- CAR T Cells
- Bacterial Therapy
- AAV
- Immunotherapy
- Gene Therapy
- Tumor Regression
- Viral Vectors
- Tumor Targeting
- Cancer Therapy
- HDAC Inhibitors
- Fibroblast Activation Protein
- BET Bromodomains
- DNA Methylation
- Lower Urinary Tract Symptoms
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Gene Therapy172 topics
- Immunotherapy152 topics
- Tumor Regression152 topics
- AAV91 topic
- Viral Vectors91 topic
- Bacterial Therapy81 topic
- Tumor Targeting81 topic
- CAR T Cells71 topic
- Cancer Therapy72 topics
- Chimeric Antigen Receptor71 topic
- HDAC Inhibitors41 topic
- Histone Deacetylases41 topic
- Fibroblast Activation Protein31 topic
- Tumor Microenvironment31 topic
- BET Bromodomains21 topic
- Benign Prostatic Hyperplasia21 topic
- DNA Methylation21 topic
- Histone Modification21 topic
- Lower Urinary Tract Symptoms21 topic
- PROTACs21 topic
Where does Hilary McElwaine-Johnn work?
Hilary McElwaine-Johnn's main affiliation in the publication record is PsiOxus Therapeutics (United Kingdom), United Kingdom.
How many publications and citations does Hilary McElwaine-Johnn have?
OpenAlex counts 27 works and 354 citations for Hilary McElwaine-Johnn, an h-index of 5, ranking #2,392,996 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hilary McElwaine-Johnn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.